Massachusetts Court Passes on New England Biolabs' Lawsuit Alleging IP Theft; Company to Appeal | GenomeWeb

NEW YORK (GenomeWeb News) – Following a Massachusetts court's decision not to rule on the merits of a case involving the alleged theft of intellectual property, New England Biolabs said on Wednesday that it plans to appeal the decision.

In 2011, NEB sued Enzymatics and three former NEB employees accusing them of stealing proprietary information "of significant scientific and commercial value" from NEB and using that information to form Enzymatics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.